BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Medtech Medical Diagnostic

Caliway Receives Initial Approval for CBL-514 Phase 3 Fat Reduction Study

"We are all delighted to see CBL-514 showing its potential to become the new, promising, non-invasive fat reduction treatment in the previous Pha...

January 24, 2024 | News

FDA Designates Amadix's Blood Test as Breakthrough Device for Colorectal Cancer Screening

PreveCol®, a blood test for oncological diagnosis, has obtained US recognition for its efficacy in detecting precancerous lesions compared to existin...

January 24, 2024 | Regulatory

First Myeloma Patient Treated with CAR-T Successfully Released

The foreign patient was first diagnosed with multiple myeloma in 2008. Despite multiple treatments including chemotherapy, immunotherapy, target treatment,...

January 23, 2024 | News

Fujirebio and Agappe Collaborate on CLIA-Based Immunoassay

In a significant move, Agappe and Fujirebio have revealed plans to launch these products in June 2024. The project has already achieved significant progres...

January 22, 2024 | News

AstraZeneca's IMFINZI Combo Shows Significantly Improved Survival in Liver Cancer

Positive results from the EMERALD-1 Phase III trial showed AstraZeneca’s IMFINZI® (durvalumab) in combination with TACE and bevacizumab demo...

January 22, 2024 | News

Qure.ai and Project Data Sphere Merge Big Pharma Insights with Deep AI for Advancing Cancer Care

In a pivotal stride toward advancing cancer care, Qure.ai, a leader in artificial intelligence (AI) solutions for medical imaging, and Project Data Sp...

January 19, 2024 | News

Lunit AI to Enhance Samsung's X-ray Devices for Chest Screening

Three-year supply contract: Lunit INSIGHT CXR and Lunit INSIGHT CXR Triage to enhance lung abnormality detection in Samsung's premium X-ray devices &nbs...

January 17, 2024 | News

Immunexpress' SeptiCyte RAPID® Gains TGA Clearance in Australia

Immunexpress, a molecular diagnostic company focused on improving outcomes for suspected sepsis patients, today announced that SeptiCyte® RAPID has rec...

January 17, 2024 | News

PulseAI's AI Algorithm Revolutionizes Consumer ECG Diagnostics

PulseAI, a leader in artificial intelligence healthcare solutions, announced a significant advancement in consumer device electrocardiogram (ECG) mon...

January 15, 2024 | News

GE HealthCare to Acquire MIM Software in New Agreement

The anticipated acquisition aligns to GE HealthCare’s precision care strategy with the goal of strengthening the company’s digital solutions ...

January 09, 2024 | News

Singapore's 2024 Cosmetic Surgery and Medical Aesthetics Trends Revealed

Dr Ivan Puah, Medical Director of Amaris B. Clinic and Chairman of the Lipo Peer Review Committee in Singapore, observes three shifts, and amongs...

January 08, 2024 | News

Merck Broadens Colorectal Cancer Portfolio via Licensing Deal with Inspirna

First-in-class ompenaclid (RGX-202) currently in Phase II development for RAS-mutated advanced or metastatic colorectal cancer Collaboration includes ex...

January 05, 2024 | News

Ribo and Boehringer Ingelheim Collaborate on Liver Disease Treatments

More than 440 million people worldwide are estimated to live with NASH, an inflammatory liver disease that is caused by accumulation of fat in the liver. O...

January 04, 2024 | News

Glenmark Launches First Biosimilar of Liraglutide, a Popular Anti-Diabetic Drug in India

‐ The anti‐diabetic biosimilar has been launched under the brand name Lirafit™, and is indicated for improving glycemic control in adult ...

January 03, 2024 | News

Stay Connected